Ira Duarte
Director Financiero/CFO en HERON THERAPEUTICS, INC. .
Fortuna: 434 146 $ al 30/04/2024
Cargos activos de Ira Duarte
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
TERRASCEND CORP. | Director/Miembro de la Junta | 02/12/2022 | - |
Independent Dir/Board Member | 02/12/2022 | - | |
HERON THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 29/03/2024 | - |
Director Financiero/CFO | 16/06/2023 | - | |
Contacto de Relaciones con Inversores | 16/06/2023 | - | |
Public Communications Contact | 16/06/2023 | - |
Historial de carrera de Ira Duarte
Antiguos cargos conocidos de Ira Duarte.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
VELOXIS PHARMACEUTICALS A/S | Comptroller/Controller/Auditor | 01/02/2016 | 01/01/2023 |
Director Financiero/CFO | 24/09/2018 | 01/01/2023 | |
Public Communications Contact | - | 01/01/2023 | |
BIODELIVERY SCIENCES INTERNATIONAL, INC. | Comptroller/Controller/Auditor | 01/01/2014 | 01/01/2016 |
CORNERSTONE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/06/2009 | 01/10/2013 |
Corporate Officer/Principal | - | 01/06/2009 | |
Ernst & Young A/S
Ernst & Young A/S Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young A/S is a consulting firm that provides analytics consulting services, assurance, tax, and transaction services to help clients solve their toughest challenges and build a better working world. The company is based in Aabyhoj, Denmark. The Danish company's analytics consulting services utilize the latest technology to integrate data and analytics throughout clients' business processes and operations. Additionally, EY Sustainability Tax professionals can help businesses realize their corporate sustainability strategy. | Corporate Officer/Principal | - | - |
Formación de Ira Duarte.
Florida Atlantic University | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 5 |
Dinamarca | 3 |
Canadá | 2 |
Operativa
Comptroller/Controller/Auditor | 4 |
Director of Finance/CFO | 2 |
Public Communications Contact | 2 |
Sectorial
Health Technology | 5 |
Consumer Services | 2 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
TERRASCEND CORP. | Process Industries |
HERON THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 4 |
---|---|
Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
Cornerstone Therapeutics, Inc.
Cornerstone Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cornerstone Therapeutics, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for the hospital, rare disease and adjacent specialty care settings. It acquires, develops and commercializes prescription pharmaceutical drugs. The company was founded on October 31, 2008 and is headquartered in Cary, NC. | Health Technology |
Ernst & Young A/S
Ernst & Young A/S Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young A/S is a consulting firm that provides analytics consulting services, assurance, tax, and transaction services to help clients solve their toughest challenges and build a better working world. The company is based in Aabyhoj, Denmark. The Danish company's analytics consulting services utilize the latest technology to integrate data and analytics throughout clients' business processes and operations. Additionally, EY Sustainability Tax professionals can help businesses realize their corporate sustainability strategy. | Commercial Services |
BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
- Bolsa de valores
- Insiders
- Ira Duarte
- Experiencia